Taxonomy: Cellular organisms; Eukaryota; Opisthokonta; Metazoa; Eumetazoa; Bilateria; Deuterostomia; Chordata; Craniata; Vertebrata; Gnathostomata; Teleostomi; Euteleostomi; Sarcopterygii; Dipnotetrapodomorpha; Tetrapoda; Amniota; Mammalia; Theria; Eutheria; Boreoeutheria; Laurasiatheria; Artiodactyla; Tylopoda; Camelidae; Vicugna,
Latin Name:
Vicugna pacos
Tested tissues: Frontal, Liver, Lung, PBMC,
Project | Date | Technology | Tissue | Condition | Cell | PMID/DOI |
---|---|---|---|---|---|---|
Vthunter_0001 | 2021.04 | 10X Genomics | Frontal | Normal | 3583 | Link |
Vthunter_0002 | 2021.04 | 10X Genomics | Liver | Normal | 10408 | Link |
Vthunter_0003 | 2021.04 | 10X Genomics | Lung | Normal | 1430 | Link |
Vthunter_0059 | 2021.04 | iDrop | PBMC | Normal | 793 | Link |
Virus | Virus Name | GeneTop 5 cell types expressing viral receptor ordered by expression proportion |
---|---|---|
Human betaherpesvirus 6 |
Frontal-Endothelial cells : 100.00% ; PBMC-B cells : 81.90% ; PBMC-T cells : 76.21% ; PBMC-Neutrophil : 72.16% ; Frontal-Inhibitory neurons : 46.15% ; |
|
Human betaherpesvirus 6A |
Frontal-Endothelial cells : 100.00% ; PBMC-B cells : 81.90% ; PBMC-T cells : 76.21% ; PBMC-Neutrophil : 72.16% ; Frontal-Inhibitory neurons : 46.15% ; |
|
Measles morbillivirus |
Frontal-Endothelial cells : 100.00% ; PBMC-B cells : 81.90% ; PBMC-T cells : 76.21% ; PBMC-Neutrophil : 72.16% ; Frontal-Inhibitory neurons : 46.15% ; |
|
Bovine viral diarrhea virus 1 |
Frontal-Endothelial cells : 100.00% ; PBMC-B cells : 81.90% ; PBMC-T cells : 76.21% ; PBMC-Neutrophil : 72.16% ; Frontal-Inhibitory neurons : 46.15% ; |
|
Hepacivirus C |
Frontal-Endothelial cells : 100.00% ; Frontal-Astrocytes : 80.84% ; Frontal-Inhibitory neurons : 80.77% ; Frontal-Excitatory neurons : 74.49% ; PBMC-B cells : 67.62% ; Frontal-Endothelial cells : 93.33% ; Liver-Hepatocytes : 40.54% ; Lung-ATII : 21.32% ; Lung-ATI : 19.05% ; Frontal-Endothelial cells : 86.67% ; Frontal-Excitatory neurons : 53.42% ; Frontal-Inhibitory neurons : 29.49% ; Liver-Hepatocytes : 25.02% ; Frontal-Oligodendrocyte progenitor cells : 21.33% ; Frontal-Endothelial cells : 86.67% ; Frontal-Excitatory neurons : 82.58% ; Frontal-Inhibitory neurons : 78.21% ; PBMC-Neutrophil : 40.00% ; Liver-Hepatic stellate cells : 31.30% ; Frontal-Endothelial cells : 80.00% ; Liver-Hepatocytes : 70.79% ; Frontal-Oligodendrocyte progenitor cells : 44.44% ; Frontal-Astrocytes : 37.29% ; Frontal-Inhibitory neurons : 28.21% ; Frontal-Endothelial cells : 60.00% ; Liver-Hepatocytes : 36.42% ; Frontal-Excitatory neurons : 31.34% ; Frontal-Astrocytes : 23.26% ; Frontal-Inhibitory neurons : 20.51% ; Frontal-Endothelial cells : 40.00% ; Liver-Hepatocytes : 29.54% ; |
|
Rabies lyssavirus | ||
Human mastadenovirus B | ||
Human mastadenovirus D |
Frontal-Endothelial cells : 100.00% ; PBMC-B cells : 81.90% ; PBMC-T cells : 76.21% ; PBMC-Neutrophil : 72.16% ; Frontal-Inhibitory neurons : 46.15% ; Frontal-Excitatory neurons : 84.99% ; Frontal-Inhibitory neurons : 74.36% ; Liver-Cholangiocytes : 25.41% ; Liver-Hepatocytes : 24.78% ; Lung-ATI : 19.05% ; |
|
Classical swine fever virus | ||
Vesicular stomatitis virus |
Frontal-Excitatory neurons : 97.28% ; Frontal-Inhibitory neurons : 87.18% ; Frontal-Endothelial cells : 80.00% ; Frontal-Microglia : 70.59% ; Frontal-Astrocytes : 55.87% ; Frontal-Endothelial cells : 60.00% ; Liver-Hepatocytes : 36.42% ; Frontal-Excitatory neurons : 31.34% ; Frontal-Astrocytes : 23.26% ; Frontal-Inhibitory neurons : 20.51% ; |
|
Influenza A virus |
Frontal-Excitatory neurons : 97.28% ; Frontal-Inhibitory neurons : 87.18% ; Frontal-Endothelial cells : 80.00% ; Frontal-Microglia : 70.59% ; Frontal-Astrocytes : 55.87% ; Frontal-Excitatory neurons : 82.81% ; Frontal-Inhibitory neurons : 55.13% ; Frontal-Endothelial cells : 20.00% ; Frontal-Endothelial cells : 80.00% ; Frontal-Excitatory neurons : 50.00% ; PBMC-Neutrophil : 36.08% ; Frontal-Endothelial cells : 80.00% ; Liver-Hepatocytes : 70.79% ; Frontal-Oligodendrocyte progenitor cells : 44.44% ; Frontal-Astrocytes : 37.29% ; Frontal-Inhibitory neurons : 28.21% ; |
|
Human gammaherpesvirus 4 | ||
Human rotavirus strain WA |
Frontal-Endothelial cells : 93.33% ; Frontal-Excitatory neurons : 53.19% ; Frontal-Inhibitory neurons : 50.00% ; PBMC-Neutrophil : 30.98% ; PBMC-B cells : 28.57% ; Frontal-Endothelial cells : 60.00% ; Liver-Hepatocytes : 27.75% ; Lung-ATII : 21.32% ; Lung-Endothelial cells : 33.99% ; |
|
Human parvovirus B19 | ||
Mammalian orthoreovirus |
Frontal-Endothelial cells : 93.33% ; Frontal-Excitatory neurons : 53.19% ; Frontal-Inhibitory neurons : 50.00% ; PBMC-Neutrophil : 30.98% ; PBMC-B cells : 28.57% ; Frontal-Excitatory neurons : 91.60% ; Frontal-Endothelial cells : 46.67% ; Frontal-Inhibitory neurons : 44.87% ; Frontal-Astrocytes : 18.70% ; Frontal-Endothelial cells : 60.00% ; Liver-Hepatocytes : 27.75% ; Lung-ATII : 21.32% ; |
|
Human immunodeficiency virus 2 |
PBMC-Neutrophil : 93.33% ; PBMC-T cells : 83.14% ; PBMC-B cells : 81.90% ; Frontal-Endothelial cells : 20.00% ; |
|
Equid alphaherpesvirus 1 | ||
Simian rotavirus A strain RRV |
Frontal-Endothelial cells : 93.33% ; Frontal-Inhibitory neurons : 92.31% ; Frontal-Excitatory neurons : 87.01% ; Frontal-Astrocytes : 70.92% ; PBMC-Neutrophil : 68.63% ; Frontal-Endothelial cells : 93.33% ; Frontal-Excitatory neurons : 53.19% ; Frontal-Inhibitory neurons : 50.00% ; PBMC-Neutrophil : 30.98% ; PBMC-B cells : 28.57% ; Frontal-Oligodendrocyte progenitor cells : 62.22% ; Frontal-Endothelial cells : 60.00% ; Frontal-Astrocytes : 56.67% ; Frontal-Oligodendrocytes : 43.95% ; Frontal-Excitatory neurons : 35.77% ; Frontal-Endothelial cells : 60.00% ; Liver-Hepatocytes : 27.75% ; Lung-ATII : 21.32% ; Lung-Endothelial cells : 33.99% ; Liver-Kupffer cells : 18.28% ; |
|
Human metapneumovirus | ||
Human immunodeficiency virus 1 |
PBMC-Neutrophil : 93.33% ; PBMC-T cells : 83.14% ; PBMC-B cells : 81.90% ; Frontal-Endothelial cells : 20.00% ; |
|
Echovirus E1 | ||
Human betaherpesvirus 5 |
Frontal-Endothelial cells : 93.33% ; Frontal-Excitatory neurons : 53.19% ; Frontal-Inhibitory neurons : 50.00% ; PBMC-Neutrophil : 30.98% ; PBMC-B cells : 28.57% ; Frontal-Endothelial cells : 80.00% ; Liver-Hepatocytes : 70.79% ; Frontal-Oligodendrocyte progenitor cells : 44.44% ; Frontal-Astrocytes : 37.29% ; Frontal-Inhibitory neurons : 28.21% ; Frontal-Oligodendrocyte progenitor cells : 62.22% ; Frontal-Endothelial cells : 60.00% ; Frontal-Astrocytes : 56.67% ; Frontal-Oligodendrocytes : 43.95% ; Frontal-Excitatory neurons : 35.77% ; Lung-Epithelial : 41.49% ; Frontal-Endothelial cells : 20.00% ; Liver-Kupffer cells : 18.28% ; |
|
Foot-and-mouth disease virus |
Frontal-Endothelial cells : 93.33% ; Frontal-Excitatory neurons : 53.19% ; Frontal-Inhibitory neurons : 50.00% ; PBMC-Neutrophil : 30.98% ; PBMC-B cells : 28.57% ; Frontal-Oligodendrocyte progenitor cells : 62.22% ; Frontal-Endothelial cells : 60.00% ; Frontal-Astrocytes : 56.67% ; Frontal-Oligodendrocytes : 43.95% ; Frontal-Excitatory neurons : 35.77% ; Frontal-Oligodendrocyte progenitor cells : 55.11% ; Frontal-Excitatory neurons : 45.72% ; Frontal-Astrocytes : 40.02% ; Frontal-Oligodendrocytes : 35.50% ; Frontal-Microglia : 24.37% ; Lung-ATII : 50.74% ; Lung-Epithelial : 34.04% ; Lung-ATI : 28.57% ; PBMC-Neutrophil : 27.45% ; Frontal-Endothelial cells : 20.00% ; Liver-Kupffer cells : 18.28% ; |
|
Adeno-associated virus - 2 |
Frontal-Endothelial cells : 93.33% ; Frontal-Excitatory neurons : 53.19% ; Frontal-Inhibitory neurons : 50.00% ; PBMC-Neutrophil : 30.98% ; PBMC-B cells : 28.57% ; PBMC-Neutrophil : 92.94% ; PBMC-T cells : 90.53% ; PBMC-B cells : 90.48% ; Frontal-Endothelial cells : 46.67% ; Frontal-Inhibitory neurons : 70.51% ; Frontal-Excitatory neurons : 70.22% ; Frontal-Endothelial cells : 53.33% ; Liver-Hepatocytes : 50.75% ; Lung-ATII : 42.65% ; PBMC-Neutrophil : 27.45% ; Frontal-Endothelial cells : 20.00% ; |
|
Echovirus E8 | ||
Porcine endogenous retrovirus A |
Frontal-Endothelial cells : 93.33% ; Frontal-Inhibitory neurons : 47.44% ; Frontal-Excitatory neurons : 45.72% ; Liver-Hepatocytes : 21.36% ; |
|
Feline immunodeficiency virus |
PBMC-Neutrophil : 93.33% ; PBMC-T cells : 83.14% ; PBMC-B cells : 81.90% ; Frontal-Endothelial cells : 20.00% ; |
|
Adeno-associated virus - 3 |
PBMC-Neutrophil : 92.94% ; PBMC-T cells : 90.53% ; PBMC-B cells : 90.48% ; Frontal-Endothelial cells : 46.67% ; |
|
Adeno-associated virus - 8 |
PBMC-Neutrophil : 92.94% ; PBMC-T cells : 90.53% ; PBMC-B cells : 90.48% ; Frontal-Endothelial cells : 46.67% ; |
|
Dengue virus |
PBMC-Neutrophil : 92.94% ; PBMC-T cells : 90.53% ; PBMC-B cells : 90.48% ; Frontal-Endothelial cells : 46.67% ; Frontal-Endothelial cells : 53.33% ; Frontal-Microglia : 26.89% ; Frontal-Astrocytes : 19.50% ; Liver-Hepatocytes : 29.54% ; Frontal-Excitatory neurons : 29.16% ; Frontal-Inhibitory neurons : 25.64% ; PBMC-Neutrophil : 23.92% ; |
|
Sindbis virus |
PBMC-Neutrophil : 92.94% ; PBMC-T cells : 90.53% ; PBMC-B cells : 90.48% ; Frontal-Endothelial cells : 46.67% ; |
|
Adeno-associated virus 9 |
PBMC-Neutrophil : 92.94% ; PBMC-T cells : 90.53% ; PBMC-B cells : 90.48% ; Frontal-Endothelial cells : 46.67% ; |
|
Venezuelan equine encephalitis virus |
PBMC-Neutrophil : 92.94% ; PBMC-T cells : 90.53% ; PBMC-B cells : 90.48% ; Frontal-Endothelial cells : 46.67% ; |
|
Lymphocytic choriomeningitis mammarenavirus |
Liver-Liver sinusoidal endothelial cells : 90.25% ; Liver-Hepatocytes : 39.88% ; Liver-Immune cells : 39.26% ; Liver-Hepatic stellate cells : 37.67% ; Liver-Kupffer cells : 36.57% ; Frontal-Endothelial cells : 60.00% ; Frontal-Excitatory neurons : 53.34% ; Frontal-Inhibitory neurons : 52.56% ; Frontal-Astrocytes : 39.11% ; Lung-Fibroblasts : 30.60% ; Frontal-Endothelial cells : 53.33% ; Frontal-Microglia : 26.89% ; Frontal-Astrocytes : 19.50% ; |
|
Japanese encephalitis virus |
Liver-Liver sinusoidal endothelial cells : 90.25% ; Liver-Hepatocytes : 39.88% ; Liver-Immune cells : 39.26% ; Liver-Hepatic stellate cells : 37.67% ; Liver-Kupffer cells : 36.57% ; |
|
Ebola virus |
Liver-Liver sinusoidal endothelial cells : 90.25% ; Liver-Hepatocytes : 39.88% ; Liver-Immune cells : 39.26% ; Liver-Hepatic stellate cells : 37.67% ; Liver-Kupffer cells : 36.57% ; Frontal-Astrocytes : 87.46% ; Frontal-Microglia : 52.94% ; Frontal-Oligodendrocyte progenitor cells : 47.56% ; Frontal-Endothelial cells : 40.00% ; Liver-Kupffer cells : 35.45% ; Frontal-Endothelial cells : 53.33% ; Frontal-Microglia : 26.89% ; Frontal-Astrocytes : 19.50% ; Frontal-Excitatory neurons : 41.14% ; Frontal-Oligodendrocytes : 36.83% ; Frontal-Astrocytes : 36.26% ; PBMC-Neutrophil : 34.90% ; Frontal-Endothelial cells : 33.33% ; Frontal-Excitatory neurons : 29.16% ; Frontal-Inhibitory neurons : 25.64% ; |
|
Lassa mammarenavirus |
Liver-Liver sinusoidal endothelial cells : 90.25% ; Liver-Hepatocytes : 39.88% ; Liver-Immune cells : 39.26% ; Liver-Hepatic stellate cells : 37.67% ; Liver-Kupffer cells : 36.57% ; Frontal-Endothelial cells : 80.00% ; Frontal-Excitatory neurons : 70.30% ; Frontal-Inhibitory neurons : 61.54% ; PBMC-Neutrophil : 44.31% ; Frontal-Microglia : 40.34% ; Frontal-Endothelial cells : 60.00% ; Frontal-Excitatory neurons : 53.34% ; Frontal-Inhibitory neurons : 52.56% ; Frontal-Astrocytes : 39.11% ; Lung-Fibroblasts : 30.60% ; Frontal-Endothelial cells : 53.33% ; Frontal-Microglia : 26.89% ; Frontal-Astrocytes : 19.50% ; Frontal-Excitatory neurons : 29.16% ; Frontal-Inhibitory neurons : 25.64% ; |
|
SARS coronavirus | ||
Marburg marburgvirus |
Frontal-Astrocytes : 87.46% ; Frontal-Microglia : 52.94% ; Frontal-Oligodendrocyte progenitor cells : 47.56% ; Frontal-Endothelial cells : 40.00% ; Liver-Kupffer cells : 35.45% ; Frontal-Endothelial cells : 53.33% ; Frontal-Microglia : 26.89% ; Frontal-Astrocytes : 19.50% ; Frontal-Excitatory neurons : 29.16% ; Frontal-Inhibitory neurons : 25.64% ; |
|
Severe acute respiratory syndrome coronavirus 2 |
Frontal-Endothelial cells : 86.67% ; Frontal-Excitatory neurons : 53.42% ; Frontal-Inhibitory neurons : 29.49% ; Liver-Hepatocytes : 25.02% ; Frontal-Oligodendrocyte progenitor cells : 21.33% ; Liver-Liver sinusoidal endothelial cells : 73.43% ; Frontal-Endothelial cells : 60.00% ; Lung-ATII : 42.65% ; Liver-Hepatic stellate cells : 37.53% ; Frontal-Microglia : 36.13% ; Frontal-Endothelial cells : 53.33% ; Frontal-Microglia : 26.89% ; Frontal-Astrocytes : 19.50% ; Liver-Hepatocytes : 31.07% ; |
|
Argentinian mammarenavirus |
Frontal-Endothelial cells : 86.67% ; Frontal-Excitatory neurons : 82.58% ; Frontal-Inhibitory neurons : 78.21% ; PBMC-Neutrophil : 40.00% ; Liver-Hepatic stellate cells : 31.30% ; |
|
Feline panleukopenia virus |
Frontal-Endothelial cells : 86.67% ; Frontal-Excitatory neurons : 82.58% ; Frontal-Inhibitory neurons : 78.21% ; PBMC-Neutrophil : 40.00% ; Liver-Hepatic stellate cells : 31.30% ; |
|
Mouse mammary tumor virus |
Frontal-Endothelial cells : 86.67% ; Frontal-Excitatory neurons : 82.58% ; Frontal-Inhibitory neurons : 78.21% ; PBMC-Neutrophil : 40.00% ; Liver-Hepatic stellate cells : 31.30% ; |
|
Guanarito mammarenavirus |
Frontal-Endothelial cells : 86.67% ; Frontal-Excitatory neurons : 82.58% ; Frontal-Inhibitory neurons : 78.21% ; PBMC-Neutrophil : 40.00% ; Liver-Hepatic stellate cells : 31.30% ; |
|
Machupo mammarenavirus |
Frontal-Endothelial cells : 86.67% ; Frontal-Excitatory neurons : 82.58% ; Frontal-Inhibitory neurons : 78.21% ; PBMC-Neutrophil : 40.00% ; Liver-Hepatic stellate cells : 31.30% ; |
|
Canine parvovirus |
Frontal-Endothelial cells : 86.67% ; Frontal-Excitatory neurons : 82.58% ; Frontal-Inhibitory neurons : 78.21% ; PBMC-Neutrophil : 40.00% ; Liver-Hepatic stellate cells : 31.30% ; |
|
Coxsackievirus B4 |
Frontal-Excitatory neurons : 84.99% ; Frontal-Inhibitory neurons : 74.36% ; Liver-Cholangiocytes : 25.41% ; Liver-Hepatocytes : 24.78% ; Lung-ATI : 19.05% ; |
|
Human mastadenovirus F |
Frontal-Excitatory neurons : 84.99% ; Frontal-Inhibitory neurons : 74.36% ; Liver-Cholangiocytes : 25.41% ; Liver-Hepatocytes : 24.78% ; Lung-ATI : 19.05% ; |
|
Coxsackievirus B1 |
Frontal-Excitatory neurons : 84.99% ; Frontal-Inhibitory neurons : 74.36% ; Liver-Cholangiocytes : 25.41% ; Liver-Hepatocytes : 24.78% ; Lung-ATI : 19.05% ; Frontal-Oligodendrocyte progenitor cells : 62.22% ; Frontal-Endothelial cells : 60.00% ; Frontal-Astrocytes : 56.67% ; Frontal-Oligodendrocytes : 43.95% ; Frontal-Excitatory neurons : 35.77% ; Lung-ATII : 50.74% ; Lung-Epithelial : 34.04% ; Lung-ATI : 28.57% ; |
|
Human mastadenovirus C |
Frontal-Excitatory neurons : 84.99% ; Frontal-Inhibitory neurons : 74.36% ; Liver-Cholangiocytes : 25.41% ; Liver-Hepatocytes : 24.78% ; Lung-ATI : 19.05% ; Frontal-Endothelial cells : 66.67% ; Frontal-Microglia : 52.10% ; Liver-Hepatocytes : 29.88% ; Frontal-Astrocytes : 28.96% ; Frontal-Oligodendrocytes : 25.53% ; Frontal-Oligodendrocyte progenitor cells : 62.22% ; Frontal-Endothelial cells : 60.00% ; Frontal-Astrocytes : 56.67% ; Frontal-Oligodendrocytes : 43.95% ; Frontal-Excitatory neurons : 35.77% ; |
|
Coxsackievirus B6 |
Frontal-Excitatory neurons : 84.99% ; Frontal-Inhibitory neurons : 74.36% ; Liver-Cholangiocytes : 25.41% ; Liver-Hepatocytes : 24.78% ; Lung-ATI : 19.05% ; |
|
Coxsackievirus B5 |
Frontal-Excitatory neurons : 84.99% ; Frontal-Inhibitory neurons : 74.36% ; Liver-Cholangiocytes : 25.41% ; Liver-Hepatocytes : 24.78% ; Lung-ATI : 19.05% ; |
|
Human mastadenovirus E |
Frontal-Excitatory neurons : 84.99% ; Frontal-Inhibitory neurons : 74.36% ; Liver-Cholangiocytes : 25.41% ; Liver-Hepatocytes : 24.78% ; Lung-ATI : 19.05% ; |
|
Coxsackievirus B2 |
Frontal-Excitatory neurons : 84.99% ; Frontal-Inhibitory neurons : 74.36% ; Liver-Cholangiocytes : 25.41% ; Liver-Hepatocytes : 24.78% ; Lung-ATI : 19.05% ; |
|
Human mastadenovirus A |
Frontal-Excitatory neurons : 84.99% ; Frontal-Inhibitory neurons : 74.36% ; Liver-Cholangiocytes : 25.41% ; Liver-Hepatocytes : 24.78% ; Lung-ATI : 19.05% ; |
|
Coxsackievirus B3 |
Frontal-Excitatory neurons : 84.99% ; Frontal-Inhibitory neurons : 74.36% ; Liver-Cholangiocytes : 25.41% ; Liver-Hepatocytes : 24.78% ; Lung-ATI : 19.05% ; |
|
Hepatitis delta virus |
Liver-Hepatocytes : 84.75% ; Liver-Immune cells : 31.90% ; Liver-Hepatic stellate cells : 31.03% ; Liver-Kupffer cells : 24.63% ; Liver-Liver sinusoidal endothelial cells : 24.07% ; |
|
Rubella virus |
Frontal-Oligodendrocytes : 83.11% ; Frontal-Microglia : 25.21% ; Frontal-Excitatory neurons : 18.58% ; |
|
Enterovirus B |
Frontal-Endothelial cells : 80.00% ; Liver-Hepatocytes : 27.08% ; Frontal-Oligodendrocytes : 26.45% ; Liver-Cholangiocytes : 24.19% ; Frontal-Microglia : 23.53% ; |
|
Human papillomavirus type 16 | ||
Middle East respiratory syndrome-related coronavirus |
Liver-Hepatocytes : 78.93% ; Lung-Endothelial cells : 33.75% ; Lung-Epithelial : 28.72% ; Liver-Immune cells : 26.99% ; |
|
Amphotropic murine leukemia virus |
Frontal-Astrocytes : 77.65% ; Frontal-Endothelial cells : 60.00% ; Frontal-Oligodendrocytes : 45.98% ; Frontal-Excitatory neurons : 43.00% ; Liver-Hepatocytes : 40.09% ; |
|
Gibbon ape leukemia virus |
Frontal-Astrocytes : 77.65% ; Frontal-Endothelial cells : 60.00% ; Frontal-Oligodendrocytes : 45.98% ; Frontal-Excitatory neurons : 43.00% ; Liver-Hepatocytes : 40.09% ; PBMC-T cells : 57.97% ; Frontal-Excitatory neurons : 50.70% ; PBMC-Neutrophil : 50.20% ; PBMC-B cells : 46.67% ; Frontal-Inhibitory neurons : 34.62% ; |
|
Feline leukemia virus strain B/lambda-B1 |
Frontal-Astrocytes : 77.65% ; Frontal-Endothelial cells : 60.00% ; Frontal-Oligodendrocytes : 45.98% ; Frontal-Excitatory neurons : 43.00% ; Liver-Hepatocytes : 40.09% ; PBMC-T cells : 57.97% ; Frontal-Excitatory neurons : 50.70% ; PBMC-Neutrophil : 50.20% ; PBMC-B cells : 46.67% ; Frontal-Inhibitory neurons : 34.62% ; |
|
Polytropic murine leukemia virus |
Frontal-Endothelial cells : 73.33% ; Frontal-Excitatory neurons : 38.26% ; Frontal-Inhibitory neurons : 29.49% ; Frontal-Astrocytes : 27.59% ; |
|
Porcine reproductive and respiratory syndrome virus | ||
Ecotropic murine leukemia virus |
Frontal-Endothelial cells : 73.33% ; |
|
Xenotropic murine leukemia virus |
Frontal-Endothelial cells : 73.33% ; Frontal-Excitatory neurons : 38.26% ; Frontal-Inhibitory neurons : 29.49% ; Frontal-Astrocytes : 27.59% ; |
|
Coxsackievirus A16 |
Frontal-Excitatory neurons : 71.54% ; Frontal-Inhibitory neurons : 56.41% ; Frontal-Endothelial cells : 53.33% ; Frontal-Astrocytes : 34.32% ; Frontal-Oligodendrocytes : 27.67% ; |
|
Enterovirus A71 | ||
Coxsackievirus A21 |
PBMC-Neutrophil : 67.45% ; PBMC-B cells : 24.76% ; Liver-Liver sinusoidal endothelial cells : 24.68% ; |
|
Rhinovirus B14 |
PBMC-Neutrophil : 67.45% ; PBMC-B cells : 24.76% ; Liver-Liver sinusoidal endothelial cells : 24.68% ; |
|
Human alphaherpesvirus 1 |
Frontal-Endothelial cells : 66.67% ; Frontal-Inhibitory neurons : 28.21% ; PBMC-Neutrophil : 19.61% ; Frontal-Excitatory neurons : 18.27% ; Frontal-Oligodendrocyte progenitor cells : 62.22% ; Frontal-Endothelial cells : 60.00% ; Frontal-Astrocytes : 56.67% ; Frontal-Oligodendrocytes : 43.95% ; Frontal-Excitatory neurons : 35.77% ; Frontal-Oligodendrocyte progenitor cells : 55.11% ; Frontal-Excitatory neurons : 45.72% ; Frontal-Astrocytes : 40.02% ; Frontal-Oligodendrocytes : 35.50% ; Frontal-Microglia : 24.37% ; Lung-ATII : 50.74% ; Lung-Epithelial : 34.04% ; Lung-ATI : 28.57% ; Frontal-Excitatory neurons : 37.79% ; Frontal-Inhibitory neurons : 20.51% ; Frontal-Oligodendrocyte progenitor cells : 18.22% ; |
|
Suid alphaherpesvirus 1 | ||
Human alphaherpesvirus 2 | ||
Varicella Zoster Virus |
Frontal-Excitatory neurons : 62.44% ; Frontal-Inhibitory neurons : 48.72% ; Frontal-Endothelial cells : 46.67% ; Frontal-Astrocytes : 19.16% ; Liver-Hepatocytes : 18.94% ; |
|
Human alphaherpesvirus 3 |
Frontal-Excitatory neurons : 62.44% ; Frontal-Inhibitory neurons : 48.72% ; Frontal-Endothelial cells : 46.67% ; Frontal-Astrocytes : 19.16% ; Liver-Hepatocytes : 18.94% ; |
|
Human parechovirus 1 | ||
Human gammaherpesvirus 8 | ||
West Nile virus | ||
Coxsackievirus A9 |
Frontal-Oligodendrocyte progenitor cells : 62.22% ; Frontal-Endothelial cells : 60.00% ; Frontal-Astrocytes : 56.67% ; Frontal-Oligodendrocytes : 43.95% ; Frontal-Excitatory neurons : 35.77% ; Lung-ATII : 50.74% ; Lung-Epithelial : 34.04% ; Lung-ATI : 28.57% ; Liver-Kupffer cells : 18.28% ; |
|
Andes orthohantavirus |
Frontal-Excitatory neurons : 61.66% ; Frontal-Inhibitory neurons : 57.69% ; Frontal-Endothelial cells : 40.00% ; |
|
Sin Nombre orthohantavirus |
Frontal-Excitatory neurons : 61.66% ; Frontal-Inhibitory neurons : 57.69% ; Frontal-Endothelial cells : 40.00% ; |
|
Oliveros mammarenavirus |
Frontal-Endothelial cells : 60.00% ; Frontal-Excitatory neurons : 53.34% ; Frontal-Inhibitory neurons : 52.56% ; Frontal-Astrocytes : 39.11% ; Lung-Fibroblasts : 30.60% ; |
|
Feline calicivirus |
Frontal-Endothelial cells : 60.00% ; Liver-Hepatocytes : 27.75% ; Lung-ATII : 21.32% ; |
|
Human rhinovirus A2 |
Frontal-Endothelial cells : 60.00% ; Liver-Hepatocytes : 36.42% ; Frontal-Excitatory neurons : 31.34% ; Frontal-Astrocytes : 23.26% ; Frontal-Inhibitory neurons : 20.51% ; |
|
Latino mammarenavirus |
Frontal-Endothelial cells : 60.00% ; Frontal-Excitatory neurons : 53.34% ; Frontal-Inhibitory neurons : 52.56% ; Frontal-Astrocytes : 39.11% ; Lung-Fibroblasts : 30.60% ; |
|
Respiratory syncytial virus |
Frontal-Microglia : 57.98% ; |
|
Simian sarcoma-associated virus |
PBMC-T cells : 57.97% ; Frontal-Excitatory neurons : 50.70% ; PBMC-Neutrophil : 50.20% ; PBMC-B cells : 46.67% ; Frontal-Inhibitory neurons : 34.62% ; |
|
Feline leukemia virus strain C/FA27 |
Frontal-Excitatory neurons : 56.30% ; Frontal-Inhibitory neurons : 53.85% ; Frontal-Endothelial cells : 20.00% ; |
|
Onyong-nyong virus |
Frontal-Excitatory neurons : 53.50% ; Frontal-Inhibitory neurons : 37.18% ; Frontal-Endothelial cells : 26.67% ; Frontal-Astrocytes : 18.47% ; |
|
Ross River virus |
Frontal-Excitatory neurons : 53.50% ; Frontal-Inhibitory neurons : 37.18% ; Frontal-Endothelial cells : 26.67% ; Frontal-Astrocytes : 18.47% ; |
|
Chikungunya virus |
Frontal-Excitatory neurons : 53.50% ; Frontal-Inhibitory neurons : 37.18% ; Frontal-Endothelial cells : 26.67% ; Frontal-Astrocytes : 18.47% ; |
|
Mayaro virus |
Frontal-Excitatory neurons : 53.50% ; Frontal-Inhibitory neurons : 37.18% ; Frontal-Endothelial cells : 26.67% ; Frontal-Astrocytes : 18.47% ; |
|
Murine hepatitis virus |
Frontal-Endothelial cells : 53.33% ; Liver-Liver sinusoidal endothelial cells : 27.42% ; |
|
Zika virus |
Frontal-Endothelial cells : 53.33% ; Frontal-Microglia : 26.89% ; Frontal-Astrocytes : 19.50% ; |
|
Hendra henipavirus | ||
Nipah henipavirus | ||
Porcine epidemic diarrhea virus |
Lung-Epithelial : 41.49% ; Frontal-Endothelial cells : 20.00% ; |
|
Canine coronavirus |
Lung-Epithelial : 41.49% ; Frontal-Endothelial cells : 20.00% ; |
|
Feline coronavirus |
Lung-Epithelial : 41.49% ; Frontal-Endothelial cells : 20.00% ; |
|
Transmissible gastroenteritis virus |
Lung-Epithelial : 41.49% ; Frontal-Endothelial cells : 20.00% ; |
|
Human coronavirus 229E |
Lung-Epithelial : 41.49% ; Frontal-Endothelial cells : 20.00% ; |
|
Infectious bronchitis virus |
Lung-Epithelial : 41.49% ; Frontal-Endothelial cells : 20.00% ; |
|
Rhinovirus C |
Lung-Ciliated cells : 37.99% ; |
|
Bovine alphaherpesvirus 1 |
Frontal-Excitatory neurons : 37.79% ; Frontal-Inhibitory neurons : 20.51% ; Frontal-Oligodendrocyte progenitor cells : 18.22% ; |
|
Bovine leukemia virus |
PBMC-B cells : 36.19% ; PBMC-Neutrophil : 31.37% ; PBMC-T cells : 29.10% ; Frontal-Inhibitory neurons : 21.79% ; Frontal-Excitatory neurons : 21.00% ; |
|
Baboon endogenous virus strain M7 |
PBMC-Neutrophil : 32.16% ; Lung-Epithelial : 26.60% ; PBMC-T cells : 22.17% ; |
|
Feline endogenous virus RD114 |
PBMC-Neutrophil : 32.16% ; Lung-Epithelial : 26.60% ; PBMC-T cells : 22.17% ; |
|
Simian type D retrovirus -Tsukuba |
PBMC-Neutrophil : 32.16% ; Lung-Epithelial : 26.60% ; PBMC-T cells : 22.17% ; |
|
Hepatitis E virus |
Lung-ATI : 31.43% ; Frontal-Excitatory neurons : 31.10% ; Frontal-Inhibitory neurons : 20.51% ; |
|
Human coronavirus NL63 |
Liver-Hepatocytes : 31.07% ; |
|
Encephalomyocarditis virus |
Liver-Hepatocytes : 29.81% ; |
|
Hepatovirus A |
Frontal-Excitatory neurons : 29.16% ; Frontal-Inhibitory neurons : 25.64% ; |
|
Coxsackievirus A10 |
Frontal-Astrocytes : 22.58% ; |
|
Hantaan orthohantavirus |
Liver-Kupffer cells : 18.28% ; |